Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M McNulty

Showing results (211-220 of 232) with videos related to

Pageof 24
Sort By:
Oncotarget|May 12, 2020
Combined inhibition of PIM and CDK4/6 suppresses both mTOR signaling and Rb phosphorylation and potentiates PI3K inhibition in cancer cellsLacey M Litchfield, Karsten Boehnke, Manisha Brahmachary, et al.
Genome Medicine|January 2, 2020
Recommendations for application of the functional evidence PS3/BS3 criterion using the ACMG/AMP sequence variant interpretation frameworkSarah E Brnich, Ahmad N Abou Tayoun, Fergus J Couch, et al.
BMC Infectious Diseases|December 15, 2015
Rationale and design of FORTH: a randomised controlled trial assessing the effectiveness of HIV self-testing in increasing HIV testing frequency among gay and bisexual menMuhammad S Jamil, Garrett Prestage, Christopher K Fairley, et al.
The Lancet. HIV|February 22, 2017
Effect of availability of HIV self-testing on HIV testing frequency in gay and bisexual men at high risk of infection (FORTH): a waiting-list randomised controlled trialMuhammad S Jamil, Garrett Prestage, Christopher K Fairley, et al.
Cancer Research|January 15, 2011
Therapeutic inhibition of MAP kinase interacting kinase blocks eukaryotic initiation factor 4E phosphorylation and suppresses outgrowth of experimental lung metastasesBruce W Konicek, Jennifer R Stephens, Ann M McNulty, et al.
BMC Public Health|November 10, 2021
Sustaining success: a qualitative study of gay and bisexual men's experiences and perceptions of HIV self-testing in a randomized controlled trialYe Zhang, Rebecca J Guy, Kirsty S Smith, et al.
AIDS and Behavior|December 21, 2017
Understanding the Targeting and Uptake of HIV Testing Among Gay and Bisexual Men Attending Sexual Health ClinicsMuhammad S Jamil, Hamish McManus, Denton Callander, et al.
BMC Public Health|January 30, 2016
The acceptability and cost of a home-based chlamydia retesting strategy: findings from the REACT randomised controlled trialK S Smith, J M Kaldor, J S Hocking, et al.
Cancer Research|August 17, 2005
The protein kinase Cbeta-selective inhibitor, Enzastaurin (LY317615.HCl), suppresses signaling through the AKT pathway, induces apoptosis, and suppresses growth of human colon cancer and glioblastoma xenograftsJeremy R Graff, Ann M McNulty, Kimberly Ross Hanna, et al.
Cancer Research|April 23, 2009
eIF4E activation is commonly elevated in advanced human prostate cancers and significantly related to reduced patient survivalJeremy R Graff, Bruce W Konicek, Rebecca L Lynch, et al.
Pageof 24

Showing results (211-220 of 232) with videos related to

Sort By:
Pageof 24
Oncotarget|May 12, 2020
Combined inhibition of PIM and CDK4/6 suppresses both mTOR signaling and Rb phosphorylation and potentiates PI3K inhibition in cancer cellsLacey M Litchfield, Karsten Boehnke, Manisha Brahmachary, et al.
Genome Medicine|January 2, 2020
Recommendations for application of the functional evidence PS3/BS3 criterion using the ACMG/AMP sequence variant interpretation frameworkSarah E Brnich, Ahmad N Abou Tayoun, Fergus J Couch, et al.
BMC Infectious Diseases|December 15, 2015
Rationale and design of FORTH: a randomised controlled trial assessing the effectiveness of HIV self-testing in increasing HIV testing frequency among gay and bisexual menMuhammad S Jamil, Garrett Prestage, Christopher K Fairley, et al.
The Lancet. HIV|February 22, 2017
Effect of availability of HIV self-testing on HIV testing frequency in gay and bisexual men at high risk of infection (FORTH): a waiting-list randomised controlled trialMuhammad S Jamil, Garrett Prestage, Christopher K Fairley, et al.
Cancer Research|January 15, 2011
Therapeutic inhibition of MAP kinase interacting kinase blocks eukaryotic initiation factor 4E phosphorylation and suppresses outgrowth of experimental lung metastasesBruce W Konicek, Jennifer R Stephens, Ann M McNulty, et al.
BMC Public Health|November 10, 2021
Sustaining success: a qualitative study of gay and bisexual men's experiences and perceptions of HIV self-testing in a randomized controlled trialYe Zhang, Rebecca J Guy, Kirsty S Smith, et al.
AIDS and Behavior|December 21, 2017
Understanding the Targeting and Uptake of HIV Testing Among Gay and Bisexual Men Attending Sexual Health ClinicsMuhammad S Jamil, Hamish McManus, Denton Callander, et al.
BMC Public Health|January 30, 2016
The acceptability and cost of a home-based chlamydia retesting strategy: findings from the REACT randomised controlled trialK S Smith, J M Kaldor, J S Hocking, et al.
Cancer Research|August 17, 2005
The protein kinase Cbeta-selective inhibitor, Enzastaurin (LY317615.HCl), suppresses signaling through the AKT pathway, induces apoptosis, and suppresses growth of human colon cancer and glioblastoma xenograftsJeremy R Graff, Ann M McNulty, Kimberly Ross Hanna, et al.
Cancer Research|April 23, 2009
eIF4E activation is commonly elevated in advanced human prostate cancers and significantly related to reduced patient survivalJeremy R Graff, Bruce W Konicek, Rebecca L Lynch, et al.
Pageof 24